Ischemic preconditioning reduces caspase-related intestinal apoptosis

Area of Science:

• Gastroenterology
• Surgical Research
• Cellular Biology

Background:

• Ischemia/reperfusion (I/R) injury is a significant clinical concern, often leading to intestinal damage.
• Apoptosis and inflammation are key pathological processes in I/R injury.
• Ischemic preconditioning (IPC) is a phenomenon known to protect organs against subsequent I/R insults.

Purpose of the Study:

• To evaluate the protective efficacy of IPC against I/R-induced apoptosis and injury in the rat intestine.
• To elucidate the underlying molecular mechanisms, including caspase-3 dependent pathways and inflammatory markers.

Main Methods:

• Male Wistar rats were divided into three groups: control, I/R, and IPC.
• The I/R group experienced superior mesenteric artery occlusion followed by reperfusion.
• The IPC group received IPC protocol before the I/R procedure.
• Blood, histopathological, and immunohistochemical analyses were performed to assess injury, apoptosis, and specific markers.

Main Results:

• Ischemia/reperfusion significantly increased myeloperoxidase (MPO) and nitrate levels, indicating inflammation.
• IPC intervention markedly reduced MPO and nitrate levels compared to the I/R group.
• Fewer apoptotic cells and improved intestinal histopathology were observed in the IPC group, correlating with caspase-3 expression.

Conclusions:

• Ischemic preconditioning effectively prevents ischemia/reperfusion-induced intestinal injury and apoptosis.
• The protective mechanism involves the caspase-3 dependent pathway.
• IPC inhibits leukocyte activation and modulates the nitric oxide-related oxidoinflammatory pathway.